Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
نویسندگان
چکیده
منابع مشابه
Application of Intravitreal Bevacizumab for Circumscribed Choroidal Hemangioma
We report 3 cases of circumscribed choroidal hemangioma (CCH) effectively managed with intravitreal bevacizumab. One patient (case 1) who had recurrent CCH (1.6 mm in thickness) with prior laser photocoagulation was treated with intravitreal bevacizumab alone. Two patients (case 2 and 3) who had CCH (2.4 mm and 2.2 mm in thickness, respectively) with recent visual impairment were treated with b...
متن کاملCircumscribed Choroidal Hemangioma
Circumscribed choroidal hemangioma is an uncommon, benign vascular tumor manifesting as an orange-red mass in the posterior pole of the eye. Serous retinal detachment accounts for decreased vision in most patients. Diagnosis of this tumor is challenging with many patients initially misdiagnosed with choroidal melanoma or metastasis. Several ancillary tests such as ultrasonography, fluorescein a...
متن کاملOral Propranolol for Circumscribed Choroidal Hemangioma
INTRODUCTION Several therapeutic approaches have been developed to treat choroidal hemangioma. However, all these therapies are associated with a potential risk of damaging the overlying retina. CASE REPORT We report a case of circumscribed choroidal hemangioma (CCH) in a 59-year-old man refractory to laser treatment. Visual acuity was 20/200 and a serous macular detachment was present. The C...
متن کامل[Circumscribed choroidal hemangioma treated with photodynamic therapy].
CLINICAL CASE A 45-year-old male referred with a scotoma in the left eye of 2 months' evolution. A peripapillary tumor was found, with a basal diameter of 7 mm and thickness 3.4 mm. It was diagnosed as a circumscribed choroidal hemangioma. It was decided to treat the patient using photodynamic therapy. After 4 sessions and 17 months follow-up, the patient remained asymptomatic and visual acuity...
متن کاملIntravitreal bevacizumab for peripapillary choroidal neovascular membranes.
nesh, Kaliki, and Shields) and Pediatric Ophthalmology and Ocular Genetics Services (Drs Ganesh and Levin), Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania. Correspondence: Dr Shields, Ocular Oncology Service, Wills Eye Institute, 840 Walnut St, Ste 1440, Philadelphia, PA 19107 ([email protected]). Author Contributions: Dr Shields had full access to ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Korean Journal of Ophthalmology
سال: 2009
ISSN: 1011-8942
DOI: 10.3341/kjo.2009.23.2.127